New Hollow Fiber Membranes for AEX and CEX in Flow-Through Mode
8th Annual European BioInnovation Leaders Summit 10th - 11th February 2015
Radisson Blu Edwardian Hotel, London
Bixente MARTIRENE, MSc Senior Product Manager
Asahi Kasei Bioprocess Europe
This presentation provides an introduction to tangential flow filtration and reviews the following:
- TFF process basics and terminology
- TFF membrane technology
- TFF hardware, devices and systems
- Growing applications and the future
To learn more about this topic or collaborate with our technical experts, schedule an in-person or remote visit at our M Lab™ Collaboration Centers: www.merckmillipore.com/mlab
Scaling Strategies with Stirred Single-Use Bioreactors from Bench to Clinical...MilliporeSigma
This presentation introduces the general principles of scaling strategies with stirred single-use bioreactors, discusses key engineering parameters, and concludes with a case study of how these strategies are applied to Mobius® bioreactors from 2 liters to 2000 liters.
To learn more about this topic or collaborate with our technical experts, schedule an in-person or remote visit at our M Lab™ Collaboration Centers: www.emdmillipore.com/mlab
a brief introduction to countercurrent chromatography with its principle. working and modes of operation along with little bit of history, the types of CCC and its applications
Scale-up of high area filters for microfiltration of biological fluids - Poin...MilliporeSigma
Presented at INTERPHEX on March 21-23, 2017.
High area filters can present unique challenges when scaling up from discs to cartridges. A model was developed that can be used to estimate scaled-up performance. A new small scale scaling tool is also introduced that closely mimics the filtration behavior of the full scale filter and that can be used to confirm expected scaled-up performance.
Introduction to High Performance Liquid Chromatography-HPLCRoyan Institute
This presentation is a simple explain of HPLC which introduce this method easily. You can use this PPTx File to present in your class and seminars as well. I prepare this file to present in Tabriz University of Medical Sciences when I was a MSc Medical Nanotechnology student. It will be useful for you too.
This presentation provides an introduction to tangential flow filtration and reviews the following:
- TFF process basics and terminology
- TFF membrane technology
- TFF hardware, devices and systems
- Growing applications and the future
To learn more about this topic or collaborate with our technical experts, schedule an in-person or remote visit at our M Lab™ Collaboration Centers: www.merckmillipore.com/mlab
Scaling Strategies with Stirred Single-Use Bioreactors from Bench to Clinical...MilliporeSigma
This presentation introduces the general principles of scaling strategies with stirred single-use bioreactors, discusses key engineering parameters, and concludes with a case study of how these strategies are applied to Mobius® bioreactors from 2 liters to 2000 liters.
To learn more about this topic or collaborate with our technical experts, schedule an in-person or remote visit at our M Lab™ Collaboration Centers: www.emdmillipore.com/mlab
a brief introduction to countercurrent chromatography with its principle. working and modes of operation along with little bit of history, the types of CCC and its applications
Scale-up of high area filters for microfiltration of biological fluids - Poin...MilliporeSigma
Presented at INTERPHEX on March 21-23, 2017.
High area filters can present unique challenges when scaling up from discs to cartridges. A model was developed that can be used to estimate scaled-up performance. A new small scale scaling tool is also introduced that closely mimics the filtration behavior of the full scale filter and that can be used to confirm expected scaled-up performance.
Introduction to High Performance Liquid Chromatography-HPLCRoyan Institute
This presentation is a simple explain of HPLC which introduce this method easily. You can use this PPTx File to present in your class and seminars as well. I prepare this file to present in Tabriz University of Medical Sciences when I was a MSc Medical Nanotechnology student. It will be useful for you too.
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...MilliporeSigma
This presentation provides an introduction to tangential flow filtration applications for AAV and lentivirus and will review:
• Basics of tangential flow filtration (TFF)
• TFF AAV and lentivirus process overview
• Operating parameters optimization: flux-controlled microfiltration
• Scale up considerations
To learn more about this topic or collaborate with our technical experts, schedule a remote visit at our M Lab™ Collaboration Centers: www.emdmillipore.com/remotevisit
The fifth lecture in the module Particle Technology, delivered to second year students who have already studied basic fluid mechanics.
Filtration covers the modification of Darcys law to predictive filtration design equations as well as ones used for test data analysis. Examples of industrial equipment for filtration are included.
Today’s analytical laboratory is faced with tight deadlines to produce results from testing environmental samples. Too often, solid-phase extraction (SPE) presents a bottleneck in the analytical testing process and may cause poor analyte recoveries and highly variable. Despite advances in analytical instrumentation, sample prep often relies on tedious, manual, and expensive techniques such as liquid-liquid extraction.
Sample preparation of environmental water samples can be automated, however.. Use of automated sample preparation addresses the many challenges that laboratories face when preparing samples and can help improve sample processing turnaround times.
Chromatography presentation goes with this free on-demand webinar. Link to webinar: https://event.on24.com/eventRegistration/EventLobbyServlet?target=registration.jsp&eventid=832348&sessionid=1&key=7401504685427A0804ABBD1F956E617C&partnerrefthermo=undefined&sourcepage=register
Wastewater is produced by multiple sources, including chemical manufacturing, power generation, petroleum product extraction, and private residences. Specific industries can use knowledge of around the analytes present in wastewater to make decisions on reuse, treatment, or whether disposal is the most cost effective option. Prior to any discharge into ground or surface waters, the level of specific analytes must be determined to ensure that they do not exceed regulated limits. If these limits are being exceeded, treatment will be required. Ion Chromatography (IC) is the primary technique used for measuring the concentration of ions in wastewater and numerous methods have been developed that meet regulatory requirements. Learn about IC methods that enable accurate, consistent, and rapid measurement of both anions, such as chloride, sulfate, and bromate, and cations, such as sodium and magnesium.
Introduction to Tangential Flow Filtration (TFF)MilliporeSigma
This presentation provides an introduction to tangential flow filtration and reviews the following:
- TFF process basics and terminology
- TFF membrane technology
- TFF hardware, devices and systems
- Growing applications and the future
To learn more about this topic or collaborate with our technical experts, schedule an in-person or remote visit at our M Lab™ Collaboration Centers: www.emdmillipore.com/mlab
An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...Merck Life Sciences
View the recording here: https://bit.ly/2M6cTYD
Abstract:
Diafiltration is a critical unit operation in the downstream purification train for nearly all monoclonal antibodies and other therapeutic biomolecules, with a particular application being the final formulation step. It provides a cost-effective, efficient, and robust method for achieving > 3 logs of buffer exchange. As the biomanufacturing industry strives for more efficient and cost-conscious processes and facilities by adapting templates to be more flexible, handle larger batch sizes, require lower plant footprint, and run in an integrated or continuous mode, diafiltration has been one of the last unit operations to change. Updated technologies for chromatography, clarification, and concentration have been developed in recent years, offering significant improvements over their existing batch processing equivalents. However, it has been challenging to develop a similar intensified and continuous technology for diafiltration that exceeds established expectations around unit operation productivity while maintaining a process that is easily implementable and suitable for GMP manufacturing.
Our approach to intensified, continuous diafiltration bases the process design on membrane utilization, as opposed to flux and process time typically used for batch designs. The result is a flexible solution that offers 6-8-fold decrease in membrane area, up to 3-fold reduction in pump passes and a substantial footprint reduction. Buffer usage, extent of buffer exchange, and product yield are equivalent to a traditional constant-volume diafiltration process. The process development approach, system components, and process control rely on well-established methods and technologies, reducing risk during scaleup and manufacturing implementation.
In this webinar, you will learn:
- A new process design for continuous diafiltration and its operational robustness over a 24-hour run
- Benefits of implementing this version of intensified or continuous diafiltration in your process train
This product guide covers the basics of Millipak® Final Fill Filters. Learn how to maximize product recovery and enhance protection of your high value product.
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...MilliporeSigma
Access the interactive recording here: https://bit.ly/2DONZaQ
Webinar summary:
1000L-scale implementation of fully connected, disposable, advanced DSP platform for next generation mAb production.
Within the biopharmaceutical industry, there is a significant shift toward higher productivity processes resulting in improved economics without compromising robustness. Therefore, integrated continuous production technologies are of greatest interest.
Next Generation Biopharmaceutical Downstream Process is a European-funded collaborative project that aims at implementing a fully integrated manufacturing platform for biosimilar mAb based on continuous chromatography, in combination with single-use disposable technologies for all unit operations of DSP on pilot/small production scale together with incorporation of advanced analytical tools.
In this webinar, you will see:
* new DSP purification template producing > 3.3 kg of mAb in 2.5 days in less than 30m²
* proof of concept for the mAb manufacturing of tomorrow
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...Merck Life Sciences
Access the interactive recording here: https://bit.ly/2DONZaQ
Webinar summary:
1000L-scale implementation of fully connected, disposable, advanced DSP platform for next generation mAb production.
Within the biopharmaceutical industry, there is a significant shift toward higher productivity processes resulting in improved economics without compromising robustness. Therefore, integrated continuous production technologies are of greatest interest.
Next Generation Biopharmaceutical Downstream Process is a European-funded collaborative project that aims at implementing a fully integrated manufacturing platform for biosimilar mAb based on continuous chromatography, in combination with single-use disposable technologies for all unit operations of DSP on pilot/small production scale together with incorporation of advanced analytical tools.
In this webinar, you will see:
* new DSP purification template producing > 3.3 kg of mAb in 2.5 days in less than 30m²
* proof of concept for the mAb manufacturing of tomorrow
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...MilliporeSigma
This presentation provides an introduction to tangential flow filtration applications for AAV and lentivirus and will review:
• Basics of tangential flow filtration (TFF)
• TFF AAV and lentivirus process overview
• Operating parameters optimization: flux-controlled microfiltration
• Scale up considerations
To learn more about this topic or collaborate with our technical experts, schedule a remote visit at our M Lab™ Collaboration Centers: www.emdmillipore.com/remotevisit
The fifth lecture in the module Particle Technology, delivered to second year students who have already studied basic fluid mechanics.
Filtration covers the modification of Darcys law to predictive filtration design equations as well as ones used for test data analysis. Examples of industrial equipment for filtration are included.
Today’s analytical laboratory is faced with tight deadlines to produce results from testing environmental samples. Too often, solid-phase extraction (SPE) presents a bottleneck in the analytical testing process and may cause poor analyte recoveries and highly variable. Despite advances in analytical instrumentation, sample prep often relies on tedious, manual, and expensive techniques such as liquid-liquid extraction.
Sample preparation of environmental water samples can be automated, however.. Use of automated sample preparation addresses the many challenges that laboratories face when preparing samples and can help improve sample processing turnaround times.
Chromatography presentation goes with this free on-demand webinar. Link to webinar: https://event.on24.com/eventRegistration/EventLobbyServlet?target=registration.jsp&eventid=832348&sessionid=1&key=7401504685427A0804ABBD1F956E617C&partnerrefthermo=undefined&sourcepage=register
Wastewater is produced by multiple sources, including chemical manufacturing, power generation, petroleum product extraction, and private residences. Specific industries can use knowledge of around the analytes present in wastewater to make decisions on reuse, treatment, or whether disposal is the most cost effective option. Prior to any discharge into ground or surface waters, the level of specific analytes must be determined to ensure that they do not exceed regulated limits. If these limits are being exceeded, treatment will be required. Ion Chromatography (IC) is the primary technique used for measuring the concentration of ions in wastewater and numerous methods have been developed that meet regulatory requirements. Learn about IC methods that enable accurate, consistent, and rapid measurement of both anions, such as chloride, sulfate, and bromate, and cations, such as sodium and magnesium.
Introduction to Tangential Flow Filtration (TFF)MilliporeSigma
This presentation provides an introduction to tangential flow filtration and reviews the following:
- TFF process basics and terminology
- TFF membrane technology
- TFF hardware, devices and systems
- Growing applications and the future
To learn more about this topic or collaborate with our technical experts, schedule an in-person or remote visit at our M Lab™ Collaboration Centers: www.emdmillipore.com/mlab
An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...Merck Life Sciences
View the recording here: https://bit.ly/2M6cTYD
Abstract:
Diafiltration is a critical unit operation in the downstream purification train for nearly all monoclonal antibodies and other therapeutic biomolecules, with a particular application being the final formulation step. It provides a cost-effective, efficient, and robust method for achieving > 3 logs of buffer exchange. As the biomanufacturing industry strives for more efficient and cost-conscious processes and facilities by adapting templates to be more flexible, handle larger batch sizes, require lower plant footprint, and run in an integrated or continuous mode, diafiltration has been one of the last unit operations to change. Updated technologies for chromatography, clarification, and concentration have been developed in recent years, offering significant improvements over their existing batch processing equivalents. However, it has been challenging to develop a similar intensified and continuous technology for diafiltration that exceeds established expectations around unit operation productivity while maintaining a process that is easily implementable and suitable for GMP manufacturing.
Our approach to intensified, continuous diafiltration bases the process design on membrane utilization, as opposed to flux and process time typically used for batch designs. The result is a flexible solution that offers 6-8-fold decrease in membrane area, up to 3-fold reduction in pump passes and a substantial footprint reduction. Buffer usage, extent of buffer exchange, and product yield are equivalent to a traditional constant-volume diafiltration process. The process development approach, system components, and process control rely on well-established methods and technologies, reducing risk during scaleup and manufacturing implementation.
In this webinar, you will learn:
- A new process design for continuous diafiltration and its operational robustness over a 24-hour run
- Benefits of implementing this version of intensified or continuous diafiltration in your process train
This product guide covers the basics of Millipak® Final Fill Filters. Learn how to maximize product recovery and enhance protection of your high value product.
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...MilliporeSigma
Access the interactive recording here: https://bit.ly/2DONZaQ
Webinar summary:
1000L-scale implementation of fully connected, disposable, advanced DSP platform for next generation mAb production.
Within the biopharmaceutical industry, there is a significant shift toward higher productivity processes resulting in improved economics without compromising robustness. Therefore, integrated continuous production technologies are of greatest interest.
Next Generation Biopharmaceutical Downstream Process is a European-funded collaborative project that aims at implementing a fully integrated manufacturing platform for biosimilar mAb based on continuous chromatography, in combination with single-use disposable technologies for all unit operations of DSP on pilot/small production scale together with incorporation of advanced analytical tools.
In this webinar, you will see:
* new DSP purification template producing > 3.3 kg of mAb in 2.5 days in less than 30m²
* proof of concept for the mAb manufacturing of tomorrow
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...Merck Life Sciences
Access the interactive recording here: https://bit.ly/2DONZaQ
Webinar summary:
1000L-scale implementation of fully connected, disposable, advanced DSP platform for next generation mAb production.
Within the biopharmaceutical industry, there is a significant shift toward higher productivity processes resulting in improved economics without compromising robustness. Therefore, integrated continuous production technologies are of greatest interest.
Next Generation Biopharmaceutical Downstream Process is a European-funded collaborative project that aims at implementing a fully integrated manufacturing platform for biosimilar mAb based on continuous chromatography, in combination with single-use disposable technologies for all unit operations of DSP on pilot/small production scale together with incorporation of advanced analytical tools.
In this webinar, you will see:
* new DSP purification template producing > 3.3 kg of mAb in 2.5 days in less than 30m²
* proof of concept for the mAb manufacturing of tomorrow
BILS 2015 Tosoh Bioscience
"Making the Impossible Possible – Chromatographic Solutions for Demanding Separations in Downstream Processing"
Judith Vajda, Regina Römling and Egbert Müller
Process Development for Continuous Flow-Through Polishing Purification for mA...Merck Life Sciences
View the interactive recording here: https://bit.ly/2JYehee
Abstract:
Over the last several years, the biopharmaceutical industry has had a significant focus on connected and continuous processing to improve both process economics and plant utilization. As opposed to the traditional polishing trains comprised of bind-elute chromatography operations, an all flow-through polishing train easily enables connected and continuous processing while simultaneously improving process economics, flexibility, and productivity. Leveraging commercially available and novel prototype chemistries and devices, we investigated how a properly designed flow-through polishing train can be used to meet the stringent demands expected for mAb polishing purification. A streamlined methodology will be described to investigate the performance of individual units as well as synergies between technologies. For both individual technologies and connected processes, results will be discussed on their ability to meet purity and yield targets robustly. Finally, we will show how leveraging the integrated combination of unit operations can result in improved performance over the standard batch, segregated processing paradigm.
In this webinar, you will learn:
• New process design for continuous flow-through polishing and its operational robustness
• Economic benefits (43% savings in COGs) of implementing a robust flow-through polishing toolbox
Process Development for Continuous Flow-Through Polishing Purification for mA...MilliporeSigma
View the interactive recording : https://bit.ly/2JYehee
Abstract:
Over the last several years, the biopharmaceutical industry has had a significant focus on connected and continuous processing to improve both process economics and plant utilization. As opposed to the traditional polishing trains comprised of bind-elute chromatography operations, an all flow-through polishing train easily enables connected and continuous processing while simultaneously improving process economics, flexibility, and productivity. Leveraging commercially available and novel prototype chemistries and devices, we investigated how a properly designed flow-through polishing train can be used to meet the stringent demands expected for mAb polishing purification. A streamlined methodology will be described to investigate the performance of individual units as well as synergies between technologies. For both individual technologies and connected processes, results will be discussed on their ability to meet purity and yield targets robustly. Finally, we will show how leveraging the integrated combination of unit operations can result in improved performance over the standard batch, segregated processing paradigm.
In this webinar, you will learn:
• New process design for continuous flow-through polishing and its operational robustness
• Economic benefits (43% savings in COGs) of implementing a robust flow-through polishing toolbox
TOYOPEARL MX-Trp-650M is designed for efficient mixed-mode steps in protein purification:
Multimodal cation exchanger
High salt tolerance
High binding capacity for IgG
Spps and its applications for bioactive peptides(Rajendra Sonawane)Rajendra Sonawane
Bioactive peptides are protein fragments which have a positive impact on the functions and conditions of
living beings. Peptides have shown several useful properties for human health, including antimicrobial, antifungal, antiviral,
and antitumor activities.
Measuring pKas, logP and Solubility by Automated titrationJon Mole
Presentation by Sirius Analytical covering measurement of pKa, LogP, LogD, Solubility, Supersaturation and precipitation kinetics.
For more details visit www.sirius-analytical.com
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit TosohGBX Summits
Improving Process Efficiency in Biomanufacturing
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit
Bench And See the Improvements at BioInnovation 2015
Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...PerkinElmer, Inc.
Phenolic antioxidants are commonly used in food to prevent the oxidation of oils. Oxidized oil and fats cause foul odor and rancidity in food products, which is a major cause for concern to the food industry. Globally, regulations vary, but current maximum allowable levels are as low as 100 μg/g (100 ppm). This application note presents a UHPLC method for the analysis of the ten most common phenolic antioxidants that may be found in such products.
High capacity chromatography resin for the capture and purification of monoclonal antibodies
Tosoh Bioscience, a provider of chromatographic solutions for the isolation and analysis of biomolecules, introduced a new Protein A chromatography resin designed for the purification of monoclonal antibodies (mAbs). It is well-suited for high capacity capturing of immunoglobulin out of high titer feedstock. TOYOPEARL AF-rProtein A HC-650F achieves 30% to 50% greater antibody adsorption than similar products. It exhibits dynamic binding capacities of greater than 70 g/L at residence times of 5 minutes and greater than 50 g/L at residence times of 2 minutes with feedstock titers from 1 g/L to more than 10 g/L.
The recombinant ligand that is linked to the well proven methacrylic polymer backbone of TOYOPEARL media has been engineered to maintain capacity even after repeated exposure to alkaline solution. Its multipoint attachment to the TOYOPEARL matrix further enhances chemical and thermal stability. In practice this pays off for a low level of Protein A leaching and also for a high resistance to alkaline solutions applied in cleaning-in-place (CIP) procedures. Due to its rigid polymer matrix TOYOPEARL AF-rProtein A HC-650F also provides excellent pressure flow characteristics.
Protein A resins constitute a substantial cost in state-of-the-art mAb purification processes. Factors such as operating cycles, capacity, and mAb titer can have an impact on total costs associated with mAb purification. The high capacity of the new TOYOPEARL AF-rProtein A HC-650F resin and its high alkaline resistance increase product throughput, reduce operating costs and increase manufacturing productivity.
Complete single-use ADC technology from development through scale-up MilliporeSigma
This webinar will talk about the benefits of single-use technologies for the manufacturing of antibody-drug conjugates and present a successful corresponding case study.
With an expected high annual growth rate of the global Antibody-drug Conjugate (ADC) market, it is essential that CMO’s have robust manufacturing platforms to ensure successful transfer to GMP production.
Single-Use Technologies provide many advantages, including improved safety, lower costs and greater flexibility. This webinar will outline the advantages of a Single Use Platform and give a case study on how it can be used to manufacture ADC projects.
In this webinar, you will learn:
● How single-use technologies can provide benefits for ADC manufacturing
● Why a solid manufacturing platform is crucial for a successful transfer to GMP production
● How a case study demonstrates the advantages of single-use equipment in a scale up to GMP production
Complete single-use ADC technology from development through scale-upMerck Life Sciences
With an expected high annual growth rate of the global Antibody-drug Conjugate (ADC) market, it is essential that CMO’s have robust manufacturing platforms to ensure successful transfer to GMP production.
Single-Use Technologies provide many advantages, including improved safety, lower costs and greater flexibility. This webinar will outline the advantages of a Single Use Platform and give a case study on how it can be used to manufacture ADC projects.
In this webinar, you will learn:
● How single-use technologies can provide benefits for ADC manufacturing
● Why a solid manufacturing platform is crucial for a successful transfer to GMP production
● How a case study demonstrates the advantages of single-use equipment in a scale up to GMP production
Over the past decade, there have been a growing number of mAb candidates entering the clinical pipeline. This results in a large increase on the demand for analytical characterization. This seminar discusses advances in analytical method development with analytical run times below 10 minutes for all routine methods with intelligent, integrated chromatography workflows. Orbitrap technology has been established as the most powerful MS technology for protein characterization. How this can be incorporated into a complete workflow for bio-pharma analysis is also discussed.
Similar to New Hollow Fiber Membranes for AEX and CEX in Flow-Through Mode (20)
BILS 2015 TU Wien exputec BioVT Pharmaceutical Engineering
"Quicker Ways to a Scalable Process Based on Sound-Science Based Methodologies"
Christoph Herwig
BILS 2015 Genethon
"Debottlenecking Downstream Process of AAV9 GeneTherapy Vectors using Customized Chromatography Resin"
Matthias Hebben, Ph.D. Bioprocess Development
BILS 2015, F. Wolpers Hamilton Bonaduz AGGBX Events
BioInnovation Leaders Summit London, February 2015
"Integrated approach to online process monitoring in Cell Culture applications"
F. Wolpers
Hamilton Bonaduz AG The Heart of Analytics
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...University of Maribor
Slides from talk:
Aleš Zamuda: Remote Sensing and Computational, Evolutionary, Supercomputing, and Intelligent Systems.
11th International Conference on Electrical, Electronics and Computer Engineering (IcETRAN), Niš, 3-6 June 2024
Inter-Society Networking Panel GRSS/MTT-S/CIS Panel Session: Promoting Connection and Cooperation
https://www.etran.rs/2024/en/home-english/
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptxRASHMI M G
Abnormal or anomalous secondary growth in plants. It defines secondary growth as an increase in plant girth due to vascular cambium or cork cambium. Anomalous secondary growth does not follow the normal pattern of a single vascular cambium producing xylem internally and phloem externally.
Richard's aventures in two entangled wonderlandsRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
hematic appreciation test is a psychological assessment tool used to measure an individual's appreciation and understanding of specific themes or topics. This test helps to evaluate an individual's ability to connect different ideas and concepts within a given theme, as well as their overall comprehension and interpretation skills. The results of the test can provide valuable insights into an individual's cognitive abilities, creativity, and critical thinking skills
ESR spectroscopy in liquid food and beverages.pptxPRIYANKA PATEL
With increasing population, people need to rely on packaged food stuffs. Packaging of food materials requires the preservation of food. There are various methods for the treatment of food to preserve them and irradiation treatment of food is one of them. It is the most common and the most harmless method for the food preservation as it does not alter the necessary micronutrients of food materials. Although irradiated food doesn’t cause any harm to the human health but still the quality assessment of food is required to provide consumers with necessary information about the food. ESR spectroscopy is the most sophisticated way to investigate the quality of the food and the free radicals induced during the processing of the food. ESR spin trapping technique is useful for the detection of highly unstable radicals in the food. The antioxidant capability of liquid food and beverages in mainly performed by spin trapping technique.
Nucleophilic Addition of carbonyl compounds.pptxSSR02
Nucleophilic addition is the most important reaction of carbonyls. Not just aldehydes and ketones, but also carboxylic acid derivatives in general.
Carbonyls undergo addition reactions with a large range of nucleophiles.
Comparing the relative basicity of the nucleophile and the product is extremely helpful in determining how reversible the addition reaction is. Reactions with Grignards and hydrides are irreversible. Reactions with weak bases like halides and carboxylates generally don’t happen.
Electronic effects (inductive effects, electron donation) have a large impact on reactivity.
Large groups adjacent to the carbonyl will slow the rate of reaction.
Neutral nucleophiles can also add to carbonyls, although their additions are generally slower and more reversible. Acid catalysis is sometimes employed to increase the rate of addition.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
What is greenhouse gasses and how many gasses are there to affect the Earth.moosaasad1975
What are greenhouse gasses how they affect the earth and its environment what is the future of the environment and earth how the weather and the climate effects.
What is greenhouse gasses and how many gasses are there to affect the Earth.
New Hollow Fiber Membranes for AEX and CEX in Flow-Through Mode
1. New Hollow Fiber Membranes for
AEX and CEX in Flow-Through Mode
Bixente MARTIRENE, MSc
Senior Product Manager
Asahi Kasei Bioprocess Europe
b.martirene@akbio.eu
8th Annual European BioInnovation Leaders Summit
10th - 11th February 2015
Radisson Blu Edwardian Hotel, London
www.ak-bio.com
2. 1) Pathogen Removal Filters
Content
Introduction
1) Hollow Fiber Membrane for AEX: QyuSpeed D
2) Hollow Fiber Membrane Prototype for CEX
3) Case study:
Combination of CEX Prototype & AEX QyuSpeed D
Conclusion
9. 9
Why Membrane vs. Resin ?
ü Mass transfer: “fast” convection vs. “slow” diffusion
ü 5-13 BV*/min vs. 0.5-2 BV/min, low pressure drop
ü 10-20 x higher loading capacity ➔ smaller BV required
ü Easy setup & operation ≈ Dead-End Filter
Introduction
* : Bed Volume = Column Volume = Membrane Volume
10. 10
Introduction
Feedback from our customers:
ü Flow-Through mode preferred for ease of use
ü AEX adsorbers more & more implemented in DSP
ü CEX mainly performed with classical resins
14. 14
QyuSpeed D AEX Adsorber
Inlet
Outlet
Hollow fiberQyuSpeed D
Module
Protein solution
with biomolecules -
Protein solution
biomolecules - free
§ Dead-End
filtration
§ Removal of
HCP, DNA,
Virus
15. 15
QyuSpeed D AEX Adsorber
Inside the pore
Grafted chain with
DEA ligands
Biomolecules -
Micropore
0.2-0.3 µm
>
16. 16
QyuSpeed D AEX Adsorber
Inside the pore
Grafted chain with
DEA ligands
Biomolecules -
Micropore
0.2-0.3 µm
H2C
C-C-O-CH2CHCH2H3C-
=
O HO
NH(CH2CH3)2
+
()
H2C
C-C-O-CH2CHCH2H3C-
=
O HO
()
NH(CH2CH3)2
+
Poly glycidyl methacrylate
Grafted chain
DEA
> >
17. 17
QyuSpeed D AEX Adsorber
ü Multipoint adsorption
ü High ligand density
Inside the pore
Grafted chain with
DEA ligands
Biomolecules -
Micropore
0.2-0.3 µm
H2C
C-C-O-CH2CHCH2H3C-
=
O HO
NH(CH2CH3)2
+
()
H2C
C-C-O-CH2CHCH2H3C-
=
O HO
()
NH(CH2CH3)2
+
Poly glycidyl methacrylate
Grafted chain
DEA
➔ high DBC & Salt tolerance
> >
20. 1) Post Protein A, in place of traditional AEX resin column
2) Post CEX w/o any prior dilution or buffer change: salt tolerant
Protein A
UFPlanova
CIEX
Centri-
fugation
Tangential MF
Depth
Filtration
or
0.2 µm
filtration
20
AEX with
QyuSpeed D
Classical Implementations of QyuSpeed D
21. 10% BSA DBC > 40 g/L-BV
10% DNA DBC @ 15 mS/cm < 30 g/L-BV
HCP reduction
25 – 99 % removal
(depending on pI of HCP)
Parvovirus LRV > 4 Log
MAb Loading capacity
Post Protein A
(in standard flow through mode)
> 2000 g/L-BV
(depending on quantities of impurities)
Number of regenerations
> 10
(tested up to 100 x with BSA)
21
Performances
22. 22
Advantages vs. other AEX Adsorbers
ü Same membrane for low or high conductivity solutions
ü “flexible” implementation: pre or post Prot. A, pre or post CEX
ü Single-use or Reusable (1M NaCl; 1N NaOH)
26. 26
New QyuSpeed Prototype for CEX
Inlet
§ Flow Through
mode = Dead-
End filtration
§ Removal of
Aggregates,
Prot. A, HCP
Outlet
Lab module
27. 27
New QyuSpeed Prototype for CEX
Inlet
Hollow fiber
Protein solution
with aggregates
Protein solution
aggregate free
Outlet
Lab module
§ Flow Through
mode = Dead-
End filtration
§ Removal of
Aggregates,
Prot. A, HCP
28. 28
Inside the pore
Grafted chain with
3 different ligands
Aggregate
Micropore
0.2-0.3 µm
>
New QyuSpeed Prototype for CEX
29. 29
Inside the pore
Grafted chain with
3 different ligands
Aggregate
Micropore
0.2-0.3 µm
Grafted chain
> >
New QyuSpeed Prototype for CEX
-R1
-R2
-R3
R1, R2 & R3 are side chains with different ligands & interactions
42. 42
Comments on the Performances
ü Performances linked to pH & Cond. ➔ optimizations
ü ~ 90 % monomer recovery (binding at the beginning)
ü Up to 95 % aggregate removal possible
ü > 1 000 g/L-BV loading capacity
➔ 10-20 x higher loading capacity vs. traditional CEX resin
43. 1) Pathogen Removal Filters
3) Case study:
Combination of CEX Prototype & AEX QyuSpeed D
44. 44
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
AEX QyuSpeed D
(FT)
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
45. 45
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
AEX QyuSpeed D
(FT)
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
Elution buffer
25mM Acetate; pH 3.4
46. 46
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
AEX QyuSpeed D
(FT)
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
Titration
pH 7.0
Elution buffer
25mM Acetate; pH 3.4
47. 47
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
AEX QyuSpeed D
(FT)
Aggregate
addition
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
Titration
pH 7.0
Elution buffer
25mM Acetate; pH 3.4
48. 48
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1041 mg/mL-BV
MAb: 2.6 mg/mL
Flow rate: 6 BV/min
AEX QyuSpeed D
(FT)
Aggregate
addition
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
Titration
pH 7.0
Elution buffer
25mM Acetate; pH 3.4
49. 49
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1041 mg/mL-BV
MAb: 2.6 mg/mL
Flow rate: 6 BV/min
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Aggregate
addition
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
Titration
pH 7.0
Elution buffer
25mM Acetate; pH 3.4
50. 50
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1041 mg/mL-BV
MAb: 2.6 mg/mL
Flow rate: 6 BV/min
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Loading: 4156 mg/mL-BV
MAb: 2.08 mg/ml
Flow rate: 6 BV/min
Aggregate
addition
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
Titration
pH 7.0
Elution buffer
25mM Acetate; pH 3.4
58. 58
Conclusion
ü Increasing use of membranes in DSP & Flow Through mode preferred
ü QyuSpeed D for AEX:
• Unique grafted-chain & hollow fiber design
• Excellent binding capacity & salt tolerance for DNA, HCP, Virus removal
• Very flexible implementation: pre or post Protein A, pre or post CEX
• Single Use or Reusable
59. 59
Conclusion
ü Increasing use of membranes in DSP & Flow Through mode preferred
ü QyuSpeed D for AEX:
• Unique grafted-chain & hollow fiber design
• Excellent binding capacity & salt tolerance for DNA, HCP, Virus removal
• Very flexible implementation: pre or post Protein A, pre or post CEX
• Single Use or Reusable
ü QyuSpeed Prototype for CEX:
• Unique grafted-chain & hollow fiber design
• Flow Through mode
• High aggregate removal & monomer recovery @ > 1000 g/L loading
• Single Use or Reusable
60. 60
Conclusion
ü Increasing use of membranes in DSP & Flow Through mode preferred
ü QyuSpeed D for AEX:
• Unique grafted-chain & hollow fiber design
• Excellent binding capacity & salt tolerance for DNA, HCP, Virus removal
• Very flexible implementation: pre or post Protein A, pre or post CEX
• Single Use or Reusable
ü QyuSpeed Prototype for CEX:
• Unique grafted-chain & hollow fiber design
• Flow Through mode
• High aggregate removal & monomer recovery @ > 1000 g/L loading
• Single Use or Reusable
ü Excellent synergy of both QyuSpeed membranes !
61. 61
Thank you to my Japanese colleagues !
Taniguchi-san
Koguma-san
Shirataki-san
Acknowledgements
62. 62
Thank you to my Japanese colleagues !
Taniguchi-san
Koguma-san
Shirataki-san
And my European Colleagues here today !
Mathithas-san and Konstantin-san
Acknowledgements
63. 63
18th Planova Workshop
ü 22nd & 23rd October 2015 in Athens, Greece
ü Technical presentations by our customers about their experience
with Planova virus removal filters, BioOptimal TFF, QyuSpeed D
ü Social activities: discover of the ancient city & special
entertainments in the evenings
ü Number of attendees: 200
ü YOU ARE WELCOME TO REGISTER !!
ü www.ak-bio.com/planova-workshop/workshop-2015-athens/description/
66. § Impurities removal by AEX (DNA, HCP),
§ Potential enhancement of Prot. A (very expensive step): better
efficiency, easier regeneration, more cycles.
66
Protein A
UFPlanova
AIEX
CIEX
Centri-
fugation
Tangential MF
Depth
Filtration
or
0.2 µm
filtration
AEX with
QyuSpeed D
or much
reduced size
Innovative Implementation: pre Prot. A
68. Protein A
UFPlanova
AIEX
CIEX
Centri-
fugation
Tangential MF
Depth
Filtration
or
0.2 µm
filtration
3 actions in 1 single step:
ü Cell culture clarification (0.2 µm; TFF mode),
ü AEX chromatography (DNA, Virus & HCP removal),
ü “Protection” of Protein A.
68
AEX with
QyuSpeed D
or much
reduced size
Other (very) Innovative Implementation:
cell culture harvesting/clarification
75. 75
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
AEX QyuSpeed D
(FT)
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
76. 76
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
AEX QyuSpeed D
(FT)
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
Elution buffer
0.1M Citrate; pH 3.4
77. 77
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
AEX QyuSpeed D
(FT)
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
Buffer change
15 mM Tris-HCl
pH 7.0; Cond. 1.4 mS/cm
Elution buffer
0.1M Citrate; pH 3.4
78. 78
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
AEX QyuSpeed D
(FT)
Aggregate
addition
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
Buffer change
15 mM Tris-HCl
pH 7.0; Cond. 1.4 mS/cm
Elution buffer
0.1M Citrate; pH 3.4
79. 79
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Aggregate
addition
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
Buffer change
15 mM Tris-HCl
pH 7.0; Cond. 1.4 mS/cm
Elution buffer
0.1M Citrate; pH 3.4
80. 80
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1067 mg/mL-MV
MAb: 5.22 mg/mL
Flow rate: 6 BV/min
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Aggregate
addition
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
Buffer change
15 mM Tris-HCl
pH 7.0; Cond. 1.4 mS/cm
Elution buffer
0.1M Citrate; pH 3.4
81. 81
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1067 mg/mL-MV
MAb: 5.22 mg/mL
Flow rate: 6 BV/min
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Loading: 4713 mg/mL-MV
MAb: 3.80 mg/ml
Flow rate: 6 BV/min
Aggregate
addition
Clarification
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
Buffer change
15 mM Tris-HCl
pH 7.0; Cond. 1.4 mS/cm
Elution buffer
0.1M Citrate; pH 3.4
82. 82
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1067 mg/mL-MV
MAb: 5.22 mg/mL
Flow rate: 6 BV/min
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Loading: 4713 mg/mL-MV
MAb: 3.80 mg/ml
Flow rate: 6 BV/min
Aggregate
addition
Clarification
Monomer 97.77 %
Dimer /
≧Trimer
1.32 % / 0.91 %
HCP 390 ppm
Protein A 0.5 ppm
Loading to CEX CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
Buffer change
15 mM Tris-HCl
pH 7.0; Cond. 1.4 mS/cm
Elution buffer
0.1M Citrate; pH 3.4
83. 83
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1067 mg/mL-MV
MAb: 5.22 mg/mL
Flow rate: 6 BV/min
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Loading: 4713 mg/mL-MV
MAb: 3.80 mg/ml
Flow rate: 6 BV/min
Aggregate
addition
Clarification
Monomer 97.77 %
Dimer /
≧Trimer
1.32 % / 0.91 %
HCP 390 ppm
Protein A 0.5 ppm
Loading to CEX
Flow Through of CEX
- 79 %
- 35 %
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
- 80 %
Buffer change
15 mM Tris-HCl
pH 7.0; Cond. 1.4 mS/cm
Monomer 99.54 %
Dimer /
≧Trimer
0.33 % / 0.14 %
HCP 254 ppm
Protein A 0.1 ppm
Monomer Recovery: 87 %
Elution buffer
0.1M Citrate; pH 3.4
84. 84
Combination CEX Prototype & AEX QyuSpeed D
Protein A
(BE)
CEX prototype
(FT)
Loading: 1067 mg/mL-MV
MAb: 5.22 mg/mL
Flow rate: 6 BV/min
Titration
pH 7.8
AEX QyuSpeed D
(FT)
Loading: 4713 mg/mL-MV
MAb: 3.80 mg/ml
Flow rate: 6 BV/min
Aggregate
addition
Clarification
Monomer 97.77 %
Dimer /
≧Trimer
1.32 % / 0.91 %
HCP 390 ppm
Protein A 0.5 ppm
Loading to CEX
Flow Through of CEX
Flow Through of AEX
- 79 %
- 35 %
CHO culture
MAb (h-IgG1), pI 8.4, Titer < 1 mg/mL
- 80 %
Buffer change
15 mM Tris-HCl
pH 7.0; Cond. 1.4 mS/cm
Monomer 99.54 %
Dimer /
≧Trimer
0.33 % / 0.14 %
HCP 254 ppm
Protein A 0.1 ppm
Monomer Recovery: 87 %
Monomer 99.79 %
Dimer /
≧Trimer
0.21 % / < DL
HCP 6 ppm
Protein A < 0.1 ppm
Monomer Recovery: 99 %
- 55 %
- 98 %
Elution buffer
0.1M Citrate; pH 3.4